Fludarabine, cyclophosphamide, and rituximab treatment achieves long-term disease-free survival in IGHV-mutated chronic lymphocytic leukemia
Safety and efficacy study of metronomic vinorelbine, cyclophosphamide plus capecitabine in metastatic breast cancer: A phase II trial
Tags: cancer, chemotherapy, cytophosphane, immunosuppressant, leukemia, lymphomas, nephrotic syndrome, nitrogen mustard alkylating agent
BASi Method Number SAP.1463
Sign up and you’ll receive the latest updates that matter to you, delivered straight to your inbox.
